ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $24,390,000 | -12.2% | 1,000,000 | -7.1% | 0.48% | -20.5% |
| Q1 2021 | $27,766,000 | -67.8% | 1,076,200 | -33.3% | 0.61% | -66.8% |
| Q4 2020 | $86,204,000 | +32.8% | 1,612,500 | +2.5% | 1.83% | +11.0% |
| Q3 2020 | $64,895,000 | +26.9% | 1,573,200 | +49.1% | 1.65% | +17.4% |
| Q2 2020 | $51,136,000 | +18.1% | 1,055,000 | +2.9% | 1.40% | -21.7% |
| Q1 2020 | $43,306,000 | +51.1% | 1,025,000 | +53.0% | 1.79% | +97.7% |
| Q4 2019 | $28,663,000 | +325.9% | 670,000 | +258.3% | 0.91% | +238.1% |
| Q3 2019 | $6,730,000 | -1.8% | 187,000 | +2.7% | 0.27% | -15.2% |
| Q3 2017 | $6,856,000 | +41.3% | 182,000 | +4.6% | 0.32% | +29.0% |
| Q2 2017 | $4,853,000 | +518.2% | 174,000 | +453.8% | 0.24% | -12.5% |
| Q4 2013 | $785,000 | – | 31,418 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |